Quality Control and Nonclinical Research on CAR-T Cell Products: General Principles and Key Issues
Adoptive cell therapy using chimeric antigen receptor T (CAR-T) cells, which is a promising cancer immunotherapy strategy, has been developing very rapidly in recent years. CAR-T cells are genetically modified T cells that can specifically recognize tumor specific antigens on the surface of tumor ce...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-02-01
|
| Series: | Engineering |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2095809918308786 |